More importantly, it was confirmed that METTL14 functioned its inhibitory role on metastasis, EMT and the PI3K/AKT pathway of ccRCC cells via N6-methylatingly disrupting ITGB4 expression. Here, ITGB4 is linked to nonpapillary renal cell carcinoma.